Lisocabtagene maraleucel for patients with relapsed or...

  • Main
  • 2020 / 9
  • Lisocabtagene maraleucel for patients with relapsed or...
Lancet (London, England) 2020 / 9

Lisocabtagene maraleucel for patients with relapsed or refractory large B-cell lymphomas (TRANSCEND NHL 001): a multicentre seamless design study

Abramson, Jeremy S, Palomba, M Lia, Gordon, Leo I, Lunning, Matthew A, Wang, Michael, Arnason, Jon, Mehta, Amitkumar, Purev, Enkhtsetseg, Maloney, David G, Andreadis, Charalambos, Sehgal, Alison, Solo
How much do you like this book?
What’s the quality of the file?
Download the book for quality assessment
What’s the quality of the downloaded files?
Journal:
The Lancet
DOI:
10.1016/S0140-6736(20)31366-0
Date:
September, 2020
File:
PDF, 831 KB
2020
Conversion to is in progress
Conversion to is failed